Exploring chemical tools to understand developmental biology and cancer.
Chemical tools for developmental biology
This study is exploring how scientists can use new tools and techniques to better understand how our bodies develop and how that knowledge might help create better treatments for cancer, so patients can look forward to new ways to fight the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10896917 on NIH RePORTER |
What this research studies
This research investigates how chemical synthesis and protein engineering can enhance our understanding of developmental biology and its implications for cancer treatment. By utilizing advanced genetic technologies and high-throughput sequencing, the team aims to identify key genes and molecular mechanisms that regulate tissue formation and contribute to cancer. The research includes developing innovative tools, such as optogenetic systems for targeted cell ablation and small-molecule inhibitors that can potentially disrupt cancer-promoting processes. Patients may benefit from new therapeutic strategies derived from these insights.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include adults with colorectal or pancreatic cancer, as well as individuals interested in the genetic and chemical factors influencing tissue development.
Not a fit: Patients with conditions unrelated to developmental biology or cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for various cancers and improve our understanding of tissue development.
How similar studies have performed: Other research has shown success in using chemical tools to explore developmental biology and cancer, indicating a promising avenue for further exploration.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Chen, James K — Stanford University
- Study coordinator: Chen, James K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.